Applied Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2019 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Applied Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2019 to Q2 2024.
  • Applied Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 6, 2024 was 115M shares, a 81.9% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 115M +51.7M +81.9% Aug 6, 2024 10-Q 2024-08-07
Q1 2024 106M +57.8M +120% Mar 5, 2024 10-K 2024-03-06
Q3 2023 77.2M +29.2M +60.7% Nov 8, 2023 10-Q 2023-11-09
Q2 2023 63.1M +15.1M +31.5% Aug 9, 2023 10-Q 2023-08-10
Q1 2023 48.1M +21.9M +83.5% Mar 22, 2023 10-K 2023-03-23
Q3 2022 48.1M +21.8M +83.3% Nov 8, 2022 10-Q 2022-11-09
Q2 2022 48M +21.8M +83.4% Aug 11, 2022 10-Q 2022-08-12
Q1 2022 26.2M +206K +0.79% Mar 9, 2022 10-K 2022-03-10
Q3 2021 26.2M +3.73M +16.6% Nov 10, 2021 10-Q 2021-11-12
Q2 2021 26.2M +3.74M +16.7% Aug 10, 2021 10-Q 2021-08-12
Q1 2021 26M +4.04M +18.4% Mar 12, 2021 10-K 2021-03-18
Q3 2020 22.5M +5.35M +31.2% Nov 11, 2020 10-Q 2020-11-12
Q2 2020 22.4M +5.38M +31.6% Aug 10, 2020 10-Q 2020-08-11
Q1 2020 22M Mar 12, 2020 10-K 2020-03-13
Q3 2019 17.1M Nov 1, 2019 10-Q 2019-11-13
Q2 2019 17.1M Jun 14, 2019 10-Q 2019-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.